EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unveiling the endogenous CRISPR-Cas system in Pseudomonas aeruginosa PAO1

Javier Alejandro Delgado-Nungaray iD, Luis Joel Figueroa-Yáñez iD, Eire Reynaga-Delgado, Ana Montserrat Corona-España, Orfil Gonzalez-Reynoso iD

PLOS ONE · 31.12.2024 · 19 (12) · e0312783

DOI: 10.1371/journal.pone.0312783 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 31.12.2024. Verfasst von Javier Alejandro Delgado-Nungaray und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Engineering Department, University Center for Exact and Engineering Sciences, University of Guadalajara, Guadalajara, Jalisco, Mexico. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, CRISPR-Cas Systems. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conahcyt.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multidrug resistance in Pseudomonas aeruginosa , a high-priority pathogen per the World Health Organization, poses a global threat due to carbapenem resistance and limited antibiotic treatments. Using the bioinformatic tools CRISPRCasFinder, CRISPRCasTyper, CRISPRloci, and CRISPRImmunity, we analyzed the genome of P . aeruginosa PAO1 and revealed an orphan CRISPR system, suggesting it may be a remnant of a type IV system due to the presence of the DinG protein. This system comprises two CRISPR arrays and noteworthy DinG and Cas3 proteins, supporting recent evidence about the association between type IV and I CRISPR systems. Additionally, we demonstrated a co-evolutionary relationship between the orphan CRISPR system in P . aeruginosa PAO1 and the mobile genetic element and prophages identified. One self-targeting spacer was identified, often associated with bacterial evolution and autoimmunity, and no Acr proteins. This research opens avenues for studying how these CRISPR arrays regulate pathogenicity and for developing alternative strategies using its endogenous orphan CRISPR system against carbapenem-resistant P . aeruginosa strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaCRISPR-Cas SystemsGenome, BacterialBacterial ProteinsClustered Regularly Interspaced Short Palindromic Repeats

Substanzen

Bacterial Proteins

Autor:innen und Institutionen

  • Chemical Engineering Department, University Center for Exact and Engineering Sciences, University of Guadalajara, Guadalajara, Jalisco, Mexico.
  • Industrial Biotechnology Unit, Center for Research and Assistance in Technology and Design of the State of Jalisco, A.C. (CIATEJ), Guadalajara, Jalisco, Mexico.
  • Pharmacobiology Department, University Center for Exact and Engineering Sciences, University of Guadalajara, Guadalajara, Jalisco, Mexico.
  • Chemical Department, University Center for Exact and Engineering Sciences, University of Guadalajara, Guadalajara, Jalisco, Mexico.

ORCID-Profile: Javier Alejandro Delgado-Nungaray, Luis Joel Figueroa-Yáñez, Orfil Gonzalez-Reynoso

Förderung

  • Conahcyt

Zitieren

APA

Delgado-Nungaray, J. A., Figueroa-Yáñez, L. J., Reynaga-Delgado, E., Corona-España, A. M., & Gonzalez-Reynoso, O. (2024). Unveiling the endogenous CRISPR-Cas system in Pseudomonas aeruginosa PAO1. PLOS ONE, 19(12), e0312783. https://doi.org/10.1371/journal.pone.0312783

Vancouver

Delgado-Nungaray JA, Figueroa-Yáñez LJ, Reynaga-Delgado E, Corona-España AM, Gonzalez-Reynoso O. Unveiling the endogenous CRISPR-Cas system in Pseudomonas aeruginosa PAO1. PLOS ONE. 2024;19(12):e0312783. doi:10.1371/journal.pone.0312783

BibTeX
@article{DelgadoNungaray2024,
  author = {Delgado-Nungaray, Javier Alejandro and Figueroa-Yáñez, Luis Joel and Reynaga-Delgado, Eire and Corona-España, Ana Montserrat and Gonzalez-Reynoso, Orfil},
  title = {Unveiling the endogenous CRISPR-Cas system in Pseudomonas aeruginosa PAO1},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {12},
  pages = {e0312783},
  doi = {10.1371/journal.pone.0312783}
}
Kostenlos starten →